Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Slow-release liothyronine plus levothyroxine versus levothyroxine alone for hypothyroidism
IRCT20100922004794N12Phase 3Completed
- Sponsor
- Dorsa Pharmaceutical
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liothyronine and levothyroxine sodium in hypothyroidism (2 arms), sponsored by Dorsa Pharmaceutical. Primary endpoints: Quality of life, TSH and 28 more. Started Dec 2024; status: completed.
02
Drugs
liothyroninelevothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on IRCT20100922004794N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100922004794N12.